|
Erythromycin EthylsuccinateDrug - Erythromycin Ethylsuccinate The trade name of the product as shown on the labeling.
Dosage -
SUSPENSION; ORAL
Active Ingredient(s) -
Erythromycin Ethylsuccinate
Strength -
EQ 400MG BASE/5ML
Applicant -
PARKE DAVIS
New Drug Application (NDA) Number -
062231
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Parke Davis Div Warner Lambert Co
Erythromycin Ethylsuccinate
Erythromycin Ethylsuccinate Eq 400mg Base/5ml Suspension; Oral
Erythromycin Ethylsuccinate Eq 200mg Base/5ml Suspension; Oral Erythromycin Ethylsuccinate Eq 400mg Base/5ml Suspension; Oral E.E.S. 400 Eq 400mg Base/5ml Suspension; Oral E-mycin E Eq 200mg Base/5ml Suspension; Oral E-mycin E Eq 400mg Base/5ml Suspension; Oral Erythromycin Ethylsuccinate Eq 200mg Base/5ml Suspension; Oral Erythromycin Ethylsuccinate Eq 400mg Base/5ml Suspension; Oral Erythromycin Ethylsuccinate Eq 200mg Base/5ml Suspension; Oral Erythromycin Ethylsuccinate Eq 400mg Base/5ml Suspension; Oral NewDrugInformation |